Total Payments
$4,022
2024 Payments
$1,012
Companies
13
Transactions
64
Medicare Patients
189
Medicare Billing
$14,355
Payment Breakdown by Category
Food & Beverage$4,022 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,022 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,187 | 34 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $739.13 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $239.20 | 2 | $0 (2024) |
| GENZYME CORPORATION | $209.94 | 4 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $128.53 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $124.97 | 1 | $0 (2022) |
| QOL Medical, LLC | $124.71 | 1 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $56.76 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $37.22 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,012 | 16 | ABBVIE INC. ($657.48) |
| 2023 | $895.70 | 17 | ABBVIE INC. ($448.15) |
| 2022 | $1,222 | 16 | ABBVIE INC. ($590.45) |
| 2021 | $892.98 | 15 | AbbVie Inc. ($491.16) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $72.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $117.85 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $123.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Gastroenterology | ||||||
| 04/12/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 02/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.50 | General |
| Category: Immunology | ||||||
| 11/14/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuroscience | ||||||
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: CNS | ||||||
| 10/26/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.48 | General |
| Category: Immunology | ||||||
| 08/30/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $103.29 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 104 | 106 | $27,329 | $8,516 |
| 2021 | 2 | 42 | 44 | $8,238 | $3,006 |
| 2020 | 2 | 43 | 43 | $13,972 | $2,833 |
Total Patients
189
Total Services
193
Medicare Billing
$14,355
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,532 | $3,380 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 32 | $7,840 | $2,678 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 31 | $5,053 | $1,768 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,904 | $689.37 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 31 | $5,053 | $1,878 | 37.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 13 | $3,185 | $1,128 | 35.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $10,714 | $2,186 | 20.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $3,258 | $646.61 | 19.8% |
About Doris Alvarez
Doris Alvarez is a Acute Care healthcare provider based in Suncity, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2014. The National Provider Identifier (NPI) number assigned to this provider is 1407272818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Doris Alvarez has received a total of $4,022 in payments from pharmaceutical and medical device companies, with $1,012 received in 2024. These payments were reported across 64 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($4,022).
As a Medicare-enrolled provider, Alvarez has provided services to 189 Medicare beneficiaries, totaling 193 services with total Medicare billing of $14,355. Data is available for 3 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Suncity, AZ
- Active Since 03/10/2014
- Last Updated 02/17/2017
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407272818
Products in Payments
- SKYRIZI (Biological) $1,042
- ENTYVIO (Biological) $658.97
- HUMIRA (Biological) $382.03
- RINVOQ (Biological) $286.90
- DUPIXENT (Biological) $266.70
- XIFAXAN (Drug) $239.20
- LINZESS (Drug) $182.33
- CREON (Drug) $163.10
- STELARA (Biological) $162.19
- ZEPOSIA (Drug) $125.00
- SUCRAID (Drug) $124.71
- REBYOTA (Biological) $109.40
- GATTEX (Drug) $80.16
- CYLTEZO (Drug) $17.39
- Linzess (Drug) $16.88
- GIMOTI (Drug) $14.88
- VIBERZI (Drug) $13.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.